ArticleJournal of Cancer2021

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis.

Wenrui Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.